“Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients” (2023) Reumatismo, 75(2). doi:10.4081/reumatismo.2023.1544.